What is Bristol-Myers Squibb's short-term investments?

Bristol-Myers Squibb (BMY) reported short-term investments of $464.00M in Q4 2025.

How has Bristol-Myers Squibb's short-term investments changed year-over-year?

Bristol-Myers Squibb's short-term investments decreased by 9.6% year-over-year, from $513.00M to $464.00M.

What is the long-term trend for Bristol-Myers Squibb's short-term investments?

Over 5 years (2020 to 2025), Bristol-Myers Squibb's short-term investments has grown at a -18.4% compound annual growth rate (CAGR), from $1.29B to $464.00M.

What does short-term investments mean?

Investments like stocks or bonds that the company plans to sell or cash out within the next twelve months.

Current Assets

Short-Term Investments

Bristol-Myers Squibb Short-Term Investments decreased by 40.2% to $464.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 9.6%, from $513.00M to $464.00M. Over 5 years (FY 2020 to FY 2025), Short-Term Investments shows a downward trend with a -18.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement

SectionCurrent Assets

CategoryLiquidity

SignalHigher is better

VolatilityModerate

First reportedQ3 2018

Last reportedQ4 2025

How to read this metric

Higher levels indicate strong liquidity and significant 'dry powder' for acquisitions or R&D, while lower levels might suggest cash is being deployed into long-term projects or shareholder returns.

Detailed definition

Highly liquid assets and marketable securities that are expected to be converted into cash within one year. For technolo...

Peer comparison

Commonly compared against other cash-rich technology peers to assess capital preservation strategies and short-term solvency.

Metric ID: short_term_investments

Historical Data

19 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25
Value	$1.95B	$2.12B	$2.99B	$2.60B	$2.48B	$1.29B	$130.00M	$274.00M	$358.00M	$171.00M	$816.00M	$340.00M	$360.00M	$204.00M	$513.00M	$907.00M	$1.00B	$776.00M	$464.00M
QoQ Change	—	+9.1%	+40.7%	-13.0%	-4.7%	-47.8%	-89.9%	+110.8%	+30.7%	-52.2%	+377.2%	-58.3%	+5.9%	-43.3%	+151.5%	+76.8%	+10.7%	-22.7%	-40.2%
YoY Change	—	—	—	—	+27.3%	-39.1%	-95.6%	-89.5%	-85.6%	-86.8%	+527.7%	+24.1%	+0.6%	+19.3%	-37.1%	+166.8%	+178.9%	+280.4%	-9.6%

Range$130.00M – $2.99B

CAGR-27.3%

Avg YoY Growth+52.1%

Median YoY Growth+0.6%

Current Streak2 quarters decline

Short-Term Investments at Other Companies

Gilead SciencesGILD View metric

PfizerPFE View metric

Merck & Co.MRK View metric

Johnson & JohnsonJNJ View metric

AbbVieABBV View metric

Eli LillyLLY View metric

Frequently Asked Questions

What is Bristol-Myers Squibb's short-term investments?: Bristol-Myers Squibb (BMY) reported short-term investments of $464.00M in Q4 2025.
How has Bristol-Myers Squibb's short-term investments changed year-over-year?: Bristol-Myers Squibb's short-term investments decreased by 9.6% year-over-year, from $513.00M to $464.00M.
What is the long-term trend for Bristol-Myers Squibb's short-term investments?: Over 5 years (2020 to 2025), Bristol-Myers Squibb's short-term investments has grown at a -18.4% compound annual growth rate (CAGR), from $1.29B to $464.00M.
What does short-term investments mean?: Investments like stocks or bonds that the company plans to sell or cash out within the next twelve months.